During the past decade, Northeast Clinical Research Center conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 24 clinical trials were completed, i.e. on average, 77.4% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 15 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northeast Clinical Research Center" #1 sponsor was "Gilead Sciences" with 4 trials, followed by "Sunovion" with 4 trials sponsored, "Palladio Biosciences" with 3 trials sponsored, "Reata Pharmaceuticals, Inc." with 3 trials sponsored and "Allena Pharmaceuticals" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northeast Clinical Research Center" #1 collaborator was "Centessa Pharmaceuticals plc" with 3 trials as a collaborator, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator, "Biocon Limited" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Cardiokine Biopharma, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Northeast Clinical Research Center" are "ADPKD" (4 trials), "Autosomal Dominant Polycystic Kidney" (4 trials), "Perennial Allergic Rhinitis" (3 trials), "Allergic Rhinitis" (2 trials) and "Chronic Kidney Disease" (2 trials). Many other conditions were trialed in "Northeast Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Northeast Clinical Research Center" are "Drug" (46 trials), "Biological" (3 trials), "Other" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Lixivaptan" (4 trials), "Darusentan" (2 trials), "SEL" (2 trials) and "ALLN-346" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northeast Clinical Research Center" are 50 trials for "All" genders.

Currently, there are NaN active trials in "Northeast Clinical Research Center". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Northeast Clinical Research Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Northeast Clinical Research Center, 6 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".